Aim-To evaluate the comparative eYcacy and tolerance of latanoprost versus timolol through a meta-analysis of randomised controlled trials (RCTs). Methods-Systematic retrieval of RCTs of latanoprost versus timolol to allow pooling of results from head to head comparison studies. Quality of trials was assessed based on randomisation, masking, and withdrawal. Sensitivity analyses were used to estimate the eVects of quality of study on outcomes. The data sources were Medline, Embase, Scientific Citation Index, Merck Glaucoma, and Pharmacia and Upjohn ophthalmology databases. There were 1256 patients with open angle glaucoma or ocular hypertension reported in 11 trials of latanoprost versus timolol. The main outcome measures were (i) percentage intraocular pressure (IOP) reduction for eYcacy; (ii) relative risk, risk diVerence, and number needed to harm for side eVects such as hyperaemia, conjunctivitis, increased pigmentation, hypotension, and bradycardia expressed as dichotomous outcomes; and (iii) reduction in systemic blood pressure and heart rate as side eVects. Results-Both 0.005% latanoprost once daily and 0.5% timolol twice daily reduced IOP. The percentage reductions in IOP from baseline (mean (SE)) produced by latanoprost and timolol were 30.2 (2.3) and 26.9 (3.4) at 3 months. The diVerence in IOP reduction between the two treatments were 5.0 (95% confidence intervals 2.8, 7.3). However, latanoprost caused iris pigmentation in more patients than timolol (relative risk = 8.01, 95% confidence intervals 1.87, 34.30). The 2 year risk with latanoprost reached 18% (51/ 277). Hyperaemia was also more often observed with latanoprost (relative risk =2.20, 95% confidence intervals 1.33, 3.64). Timolol caused a significant reduction in heart rate of 4 beats/minute (95% confidence interval 2, 6). Conclusion-This meta-analysis suggests that latanoprost is more eVective than timolol in lowering IOP. However, it often causes iris pigmentation. While current evidence suggests that this pigmentation is benign, careful lifetime evaluation of patients is still justified. (Br J Ophthalmol 2001;85:983-990)
Aim: To assess the long term (1 year) effect of myopic and hyperopic LASIK on corneal sensation and innervation. Methods: 83 eyes of 43 patients having LASIK were evaluated. According to the preoperative spherical equivalent, the eyes were divided into three groups: group 1, myopia from 20.75 to 26.00 D; group 2, myopia from 26.25 to 211.50 D; and group 3, hyperopia from 1.25 to 5.00 D. Corneal sensation was measured and in vivo confocal microscopy (IVCM) was done at the central cornea before, and at 1 month, 3 months, 6 months, and 1 year after LASIK. Results: The mean corneal sensation in group 1 was greater than in groups 2 and 3 at all postoperative measurements. The difference between group 1 on one hand and groups 2 and 3 on the other hand was statistically significant at 1 month and 3 months after LASIK and was not statistically significant afterwards. IVCM study of 27 eyes revealed that the number and length of nerve fibre bundles in the sub-basal region decreased after LASIK and was significantly lower at all times after surgery despite the return of corneal sensation to preoperative level. Conclusion: After LASIK, central corneal sensitivity is decreased for as long as 6 months or more. The results suggest that lamellar cutting of the cornea during LASIK impairs corneal sensitivity and is related to the ablation depth. The diameter of ablation too may contribute to this drop in sensitivity. The return of corneal sensations does not directly correlate with the regeneration of nerve fibres as determined by confocal imaging. Sensations return to normal values before complete restoration of normal innervation if this indeed ever occurs.
Conclusions: This study establishes a direct link between sub-basal nerves and the subBowmans nerves via distinct terminal bulbs. Limbal nerves are the thickest, are seen in all quadrants and can be traced to the corneal centre. The sub-basal nerve plexus rapidly degenerates after death but stromal and limbal nerves survive during the first five days after death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.